Radioimmunodetection of neuroblastoma cells with 1-131-radiolabelled antibodies

Cancer Biotherapy and Radiopharmaceuticals

Volumn 12, Issue 3, 1997, Pages 187-194

  Voigt, Astrid ^a   Berndt, Alexander ^a   Lauterbach, Hubert ^a   Carlsohn, Hartmut ^a   Hüller, Manfred ^a   Stiller, Klaus Jürgen ^a   Gottschild, Dietmar ^a   Zintl, Felix ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Biodistribution; Immunoscintigraphy; Iodine 131; Neuroblastoma

Indexed keywords

ANTIBODY CONJUGATE; IODINE 131; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ARTICLE; CHILDHOOD CANCER; DIAGNOSTIC IMAGING; HUMAN; HUMAN CELL; IMMUNOSCINTIGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0030788161     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1997.12.187     Document Type: Article

References (20)

1. Vaickus L, Foon KA. Overview of monoclonal antibodies in the diagnosis and therapy of cancer. Cancer Investigation 1991;9:195-209.
2. Shulkin BL, Shapiro B, Hutchinson RJ. Iodine-131-Metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. J Nucl Med 1992;33:1735-1740
3. Lastoria S, Maurea S, Caraco C, Vergara E, Maurelli L, Indolfi P, Casale F, DiTullio MT. Iodine-131 metaiodobenzyguanidine scintigraphy for localization of lesions in children with neuroblastoma. comparison with computed tomography and ultrasonography Eur J Nucl Med 1993;20:1161-1167.
4. 123I-Meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma. Acta Oncol 1995;34:505-510.
5. Berthold F, Waters W, Sieverts H, Linden A. Immunoscintigraphic imaging of MIBG-negative metastases in neuroblastoma. Am J Pediatr Hematol Oncol 1990;12:61-62.
6. Kemshead JT, Goldman A, Jones D, Pritchard J, Malpas JS, Gordon I, Malone JF, Hurley GD, Breatnach F Therapeutic application of radiolabeled monoclonal antibody UJ13A in children with disseminated neuroblastoma - A phase 1 study. Evans AE, D'Angio GJ, Knudson AG and Seeger RC (eds) Advances in Neuroblastoma Research. New York, Alan R. Liss, 1985, 533-544.
7. Cheung NKV, Yeh SDJ, Gulati S, Burch L, Kushner BH, Larson SM. Iodine-131-3F8 targeted radiotherapy of neuroblastoma (NB): a phase I clinical trial Proc AACR 1990;31:284.
8. Sautter-Bihl ML, Matzku S, Bihl H. Systemic radiotherapy with monoclonal antibodies. Strahlenther Onkol 1993;169:431-437.
9. Voigt A, Häfer R, Zintl F. J. Monoclonal antibodies against neuroblastoma. Production and preliminary characterization of their specificity. Neuroimmunol 1993;43:125-130.
10. McFarlane AS. Labelling of plasma proteins with radioactive iodine. Biochem J 1956;62:135-143.
11. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinitive antigen excess. J Immunol Meth 1984;72:77-89.
12. Serafini AN, Vargas-Cuba R, Benedetto P, Legaspi A, Feun L, Robinson D, Ardalan B, Dewanjee MK, Sevin BU, Averette H, Sfakianakis G. Clinical experience in utilizing radiolabeled monoclonal antibodies. Antibody, Immunoconjugates, Radiopharmaceuticals 1991;4:77-83.
13. Epstein AL, Khawli LA. Tumor biology and monoclonal antibodies. Overview of basic principles and clinical considerations. Antibody, Immunoconjugates, and Radiopharmaceuticals 1991,4:373-384.
14. Daghighian F, Pentlow KS, Larson SM, Graham MC, DiResta GR, Yeh SDJ, Macapinlac H, Finn RD, Arbit E, Cheung NKV. Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labeled 3F8 monoclonal antibody in glioma Eur J Nucl Med 1993;20:402-409.
15. Sautter-Bihl ML, Matzku S, Bihl H. Systemic radiotherapy with monoclonal antibodies. Strahlenther Onkol 1993;169:431-437.
16. Ugur O, Kostakoglu L, Hiu ET, Fisher DR, Garmestani K, Gansow OA, Cheung NKV, Larson SM. Comparison of the targeting characteristics of various radio-immunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating crossorgan beta doses. Nucl Med Biol 1996;23:1-8.
17. Cheung NKV, Yeh SDJ, Gulati S, Burch L, Kushner BH, Larson SM. Iodine-131-3F8 targeted radiotherapy of neuroblastoma (NB): a phase I clinical trial. Proc AACR 1990;31:284.
18. Novak-Hofer I, Amstutz H, Haldemann A, Blaser K, Morgenthaler JJ, Bläuenstein P, Schubiger PA. Radio-immunolocalization of neuroblastoma xenografts with chimeric antibody chCE7. J Nucl Med 1992;33:231-236.
19. Mach JP, Pelegrin A, Buchegger F Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Curr Opinion Immunol 1991;3 685-693.
20. Miraldi F. Monoclonal antibodies and neuroblastoma. Semin Nucl Med 1989;19:282-294.